EBOS Group Limited Stock

Equities

EBO

NZEBOE0001S6

Pharmaceuticals

End-of-day quote New Zealand S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
34.69 NZD +2.03% Intraday chart for EBOS Group Limited -1.20% -2.28%
Sales 2024 * 13.91B 8.19B Sales 2025 * 12.34B 7.26B Capitalization 6.7B 3.95B
Net income 2024 * 313M 184M Net income 2025 * 295M 174M EV / Sales 2024 * 0.57 x
Net Debt 2024 * 1.17B 688M Net Debt 2025 * 1.03B 609M EV / Sales 2025 * 0.63 x
P/E ratio 2024 *
21.6 x
P/E ratio 2025 *
22.7 x
Employees 5,000
Yield 2024 *
3.37%
Yield 2025 *
3.27%
Free-Float 80.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.03%
1 week-1.20%
Current month+1.28%
1 month-5.04%
3 months-2.34%
6 months+1.17%
Current year-2.28%
More quotes
1 week
33.85
Extreme 33.85
35.50
1 month
33.50
Extreme 33.5
36.12
Current year
33.50
Extreme 33.5
37.90
1 year
33.50
Extreme 33.5
46.00
3 years
28.89
Extreme 28.89
46.75
5 years
18.42
Extreme 18.42
46.75
10 years
8.44
Extreme 8.44
46.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-06-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 23-07-31
Members of the board TitleAgeSince
Director/Board Member 66 22-09-15
Chairman 64 03-06-30
Director/Board Member - 19-06-30
More insiders
Date Price Change Volume
24-04-19 34.69 +2.03% 235,599
24-04-18 34 -1.82% 318,616
24-04-17 34.63 -1.09% 298,052
24-04-16 35.01 -1.38% 231,456
24-04-15 35.5 +1.11% 177,041

End-of-day quote New Zealand S.E., April 18, 2024

More quotes
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. It sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
34.69 NZD
Average target price
37.57 NZD
Spread / Average Target
+8.30%
Consensus

Quarterly revenue - Rate of surprise